News on Wellness

Amid Criticism The Tamiflu Drug Analyzed To Have Saved Lives In Flu Pandemic


A new published study says four years ago the Tamiflu medicine of Roche saved lives from H1N1 swine flu pandemic. Researchers analyzed data of about 30,000 patients from 38 countries.

The new study was funded by Swiss drugmaker to reassure the government with the value of flu drug from the findings. It followed after some of the doctors criticized Tamiflu.
Jonathan Nguyen-Van-Tam and his colleagues from the University of Nottingham found in their study that treatment with neuraminidase inhibitor drugs reduced death risk by about 19 percent during the pandemic compared with no treatment.

Tamiflu is considered as the main neuraminidase inhibitor drug.

The study reveals the best benefit was found when the treatment started within two days of the symptoms began developing. Researchers say the death risk was halved.

The study is published in the Lancet Respiratory Medicine journal. It further adds that similar benefit was also found in the pregnant women and adults in the intensive care. No significant mortality reduction was though found in children.

Tamiflu is an approved drug and is stockpiled across the world by several governments during global flu outbreak. In 2009 its sales hit almost $3 billion, but thereafter it dropped with the decline in H1N1 swine flu pandemic.

Some of the researchers from non-profit organization Cochrane Collaboration have criticized the drug claiming it hardly works. They cited evidence too.

Leave a Reply

Your email address will not be published. Required fields are marked *